Walgreens Boots Alliance (WBA) to Release Quarterly Earnings on Tuesday

Walgreens Boots Alliance (NASDAQ:WBA) will post its quarterly earnings results before the market opens on Tuesday, October 15th. Analysts expect Walgreens Boots Alliance to post earnings of $0.36 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $8.87 on Tuesday. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. The business has a 50 day moving average of $9.73 and a two-hundred day moving average of $13.81. Walgreens Boots Alliance has a 52 week low of $8.22 and a 52 week high of $27.05. The company has a market cap of $7.66 billion, a P/E ratio of -1.32, a PEG ratio of 0.99 and a beta of 0.70.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were paid a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a yield of 11.27%. Walgreens Boots Alliance’s payout ratio is currently -14.84%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on WBA shares. Barclays reduced their price objective on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a research report on Tuesday, July 23rd. Evercore ISI dropped their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. Bank of America cut their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. UBS Group cut their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 3rd. Finally, Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus target price of $14.50.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.